News | RIVM

No changes to chromium (VI) adverse health effect list

No changes will be made to the list of adverse health effects that may be caused by exposure to chromium (VI) in the workplace. According to RIVM, the latest scientific literature has resulted in no new insights.

Start of invitations for the seasonal flu vaccination

The invitation for the seasonal flu vaccination will land on your doormat this autumn. The flu vaccination protects people who are more likely to become ill or seriously ill from flu because of their age or medical condition.

Chromium-6 from medical implants not harmful to health

Chromium-6 from medical implants, such as hip or knee implants, does not result in severe health damage.

Safety of materials and products already starts at the design phase

The Ministry of Infrastructure and Water Management aims to ensure that all new materials and technological developments are safe in 2050.

Onderzoeker met veiligheidsbril bekijkt preparaat

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Protection of Defence personnel against health risks of chromium-6 was inadequate

From 1984-2006, employees of the Dutch Ministry of Defence were exposed to chromium-6 during maintenance work.

Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded

Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.

Tool for risk assessment of nanomaterials in cosmetics

Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.

Nanotechnology increasingly used in medical devices

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

Cost-effective risk assessment of nanomaterials may be feasible

Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.